The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of dexamethasone in glioblastoma (GBM) patients on systemic and intratumoral T-cell responses induced by personalized neoantigen-targeting vaccine.
 
David A. Reardon
Honoraria - Abbvie; Bristol-Myers Squibb; Bristol-Myers Squibb; Cavion; Celldex; Genentech/Roche; Inovio Pharmaceuticals; Juno Therapeutics; Merck; Midatech Pharma; Momenta Pharmaceuticals; Monteris Medical; Novartis; Novocure; Oncorus; Oxigene; Regeneron; Stemline Therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb; Cavion; Celldex; Genentech/Roche; Inovio Pharmaceuticals; Juno Therapeutics; Merck; Midatech Pharma; Momenta Pharmaceuticals; Monteris Medical; Novartis; Novocure; Oncorus; Oxigene; Regeneron; Stemline Therapeutics
Research Funding - Acerta Pharma (Inst); Agenus (Inst); Celldex (Inst); EMD Serono (Inst); Incyte (Inst); Inovio Pharmaceuticals (Inst); Midatech Pharma (Inst); Tragara (Inst)
 
Donna S. Neuberg
No Relationships to Disclose
 
Derin B. Keskin
No Relationships to Disclose
 
Itay Tirosh
No Relationships to Disclose
 
Annabelle Anandappa
No Relationships to Disclose
 
Nathan D. Mathewson
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Dana-Farber Cancer Institute (Inst)
 
Jing Sun
No Relationships to Disclose
 
Sachet A Shukla
No Relationships to Disclose
 
Evisa Gjini
No Relationships to Disclose
 
Shuqiang Li
No Relationships to Disclose
 
Anita Giobbie-Hurder
No Relationships to Disclose
 
Kai Wucherpfennig
No Relationships to Disclose
 
Mario Suva
No Relationships to Disclose
 
Edward Fritsch
Employment - Neon Therapeutics
Stock and Other Ownership Interests - Neon Therapeutics
 
Scott Rodig
Honoraria - Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Keith L. Ligon
Stock and Other Ownership Interests - Travera
Consulting or Advisory Role - Midatech Pharma
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Plexxikon (Inst); Tragara (Inst); X4 Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Molecular Diagnostics Assay Patent
 
Kenneth J Livak
Patents, Royalties, Other Intellectual Property - Fluidigm
Other Relationship - Integrated DNA Technologies
 
Nir Hacohen
Leadership - Neon Therapeutics
Stock and Other Ownership Interests - Neon Therapeutics
 
Catherine J. Wu
Stock and Other Ownership Interests - Neon Therapeutics; Neon Therapeutics (I)
Consulting or Advisory Role - Neon Therapeutics; Neon Therapeutics (I)
Patents, Royalties, Other Intellectual Property - Neon Therapeutics, Advisory Board Member; Neon Therapeutics, Advisory Board Member (I)
 
Patrick Alexander Ott
Consulting or Advisory Role - Bristol-Myers Squibb; Celldex; CytomX Therapeutics; Genentech; Merck; Neon Therapeutics; Novartis; Pfizer
Research Funding - ARMO BioSciences (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Merck (Inst)